New Study Reveals Why Cannabis is Still Illegal, Legal Pot DESTROYS Big Pharma Profits

As more and more people drop prescription drugs for medical cannabis, reports like this explain why Big Pharma is scrambling to keep prohibition in place. It also explains why the DEA has such close ties to the pharmaceutical industry.

By Justin Gardner

Source: The Free Thought Project

The question of why cannabis remains illegal becomes more unavoidable by the day, as scientific evidence mounts for its medicinal powers and states continue to decriminalize the plant. The legal drugs of alcohol and nicotine kill hundreds of thousands every year and have little to no medical value – but the ingestion of cannabis kills no one, and heals many.

The war on drugs itself is an utter failure by the metrics it was supposed to address – drug availability, drug prices and drug use. With the absence of any rational basis for prohibition, it begs the question of what actually sustains it.

We know the State profits immensely from the drug war, acquiring wealth and power by arbitrarily naming certain substances “illicit.” In the modern-day corporatocracy, certain industries profit as well, most notably prisons and various entities involved in State oppression.

In the area of cannabis, perhaps the biggest beneficiary to prohibition is the pharmaceutical industry. Big Pharma tried and mostly failed to defeat the groundswell movement of cannabis legalization in many states. But it seems to have a friend in the federal Drug Enforcement Administration (DEA), which against all reason decided to keep cannabis a Schedule 1 Controlled Substance.

Big Pharma admitted that legal cannabis poses a threat to its profit, and that reality is underscored in a new analysis from New Frontier Data. If medical cannabis were adopted in all 50 states, it would siphon about $4.5 billion a year from the pharma industry.

“New Frontier Data identified nine conditions in particular to assess the impact of the legalization of cannabis would have on prescription drug use.

Among those, spending on treatments for chronic pain and post-traumatic stress disorder (PTSD) represented about 60% of the total. Overall in 2016, it was estimated that patients spent nearly $14.3 billion and $10.6 billion, respectively, to treat chronic pain and PTSD. The costs to treat sleep disorders, anxiety, epilepsy, nerve pain, chemotherapy-induced nausea and vomiting (CINV), Tourette syndrome, and glaucoma collectively accounted for the other 40% dedicated toward treatments.

There is significant savings to be realized in the health care system both to consumers and the U.S. government. It is estimated that cannabis and related products can replace between $4.4 billion and $4.9 billion of current annual spending on those existing treatments.”

In a press release, New Frontier CEO Aguirre De Carcer said, “Looking at these numbers, it would appear that medical cannabis would be a drop in the bucket when it comes to impacting the total pharmaceutical industry. However, when you start to break down the numbers by specific sectors of the industry, like chronic pain or symptoms associated with chemotherapy, which are very lucrative markets for pharmaceutical companies, you will certainly see cannabis have a major impact.

They referenced a July 2016 study which found that, on average, about 11 percent of patients in legal weed states are successfully replacing prescription drugs with medical cannabis. This, along with other studies, prompted New Frontier Data to look further into the dynamic of medical cannabis and pharmaceutical drugs.

A National Academies of Science study identified nine specific conditions where medical cannabis can have a beneficial role – including chronic pain and post-traumatic stress disorder (PTSD) – which were used by New Frontier Data for their analysis. Another report showed that taxpayers could save $1.1 billion on Medicaid prescriptions annually if medical cannabis were legalized nationwide.

Any opportunity for alternatives that could result in reduced pharmaceutical drug use might present a compelling point of discussion from a public policy standpoint,said John Kagia, executive vice president of industry analytics at New Frontier.

The problem is, public policy is largely controlled by interests that have no desire to reduce profits by reducing prescription drug consumption, and have no desire to relinquish power by decriminalizing a medicinal plant that harms no one.

Judging by DEA chief Chuck Rosenberg, his agency will continue taking the lead in government’s war on people. Only a few days ago Rosenberg reminded us of the staggering, willful ignorance that guides the drug war, stating, “Marijuana is not medicine.

Prison Town Selling Its Jails to Grow Cannabis to Save their Economy — And It’s Working

Screen-shot-2012-08-31-at-9.55.31-PM

By Justin Gardner

Source: Activist Post

A tiny California desert town is making a drastic change to reverse its downward spiral and embrace an enlightened future. For 24 years, Adelanto tried unsuccessfully to sustain its economy through prisons, but now it will be hosting a very different kind of business—cannabis cultivation.

The town became only the second city in California to permit commercial cultivation of medical cannabis, after a year of heated debate in the City Council. The persistence of John “Bug” Woodard, Jr. paid off in a 4-1 vote on Nov. 23 to allow cultivation.

“I had nothing to lose,” said Woodard. “The city could not get in any worse shape than it was. It was broke.”

Brooke Edwards Staggs of The Orange County Register describes Adelanto’s declining prison economy and the land rush that is now taking place after their decision to go to pot.

Its first prison was built in 1991, as the city braced itself for the closure of nearby George Air Force Base.

That didn’t stop Adelanto’s long slide into high unemployment and depressed property values. More than a third of the city’s nearly 33,000 residents now live below the poverty line. So it kept welcoming more prisons, banking on the promise of jobs and steady revenue in the form of an annual bed tax.

The town sold one of its four prisons to a private firm in 2010 for $28 million, and that cash is about to run out. Solar energy developers also had an interest in Adelanto, but only four projects have been constructed, producing a handful of jobs.

Now, a new kind of developer is flocking to the town.

Ky-Mani Marley, one of Bob Marley’s sons, has already signed on to license a strain of cannabis that will be grown there, according to Freddy Sayegh, the attorney on the project. Tommy Chong has also shown interest. So has B-Real of Cypress Hill fame, plus other high-profile musicians and professional athletes whose names are being kept under wraps.

One commercial real estate firm says they went from one call a week to five calls a day about purchasing land in Adelanto. Real estate prices have skyrocketed as “investors, cultivators, doctors, architects and record executives” fly across the country to see about getting in on the budding industry.

Twenty-seven companies have been permitted to set up grow operations in Adelanto, with two more pending. The first crop is expected to be produced by summer, and when it reaches full capacity, the town will be producing about 50,000 pounds of cannabis six times a year for the medical industry.

Since California approved medical cannabis use in 1996, it has finally gotten around to creating a licensing program for cannabis businesses under the Medical Marijuana Regulations and Safety Act. The state is expected to legalize recreational use this November, which will greatly increase demand for legitimate operations.

The trend of cities allowing commercial-scale cannabis cultivation is a relief for those concerned about the environmental impact of illegal grow operations. Last year we reported how many growers are carelessly polluting aquatic ecosystems with rat poison and other toxic chemicals, while drying up already stressed streams.

As more towns and cities in California permit large-scale cannabis cultivation, demand will shift to these responsible growers, which should begin to reduce the pressure on the state’s fragile aquatic ecosystems.

Adelanto, which means “progress” in Spanish, will indeed prove to be a model of progress as it transitions from a depressing economy of prisons to one that actually helps human and environmental health.

“Tomorrow, they’ll be on the correct side of history and be recognized as a city that actually embraced safety and embraced something that heals people,” said Randall Longwith, an attorney representing investors.

Not only will cannabis businesses be producing exclusive strains for distribution, but Adelanto will also serve as a hub of medical research for ailments such as pediatric epilepsy, brain tumors, and post-traumatic stress disorder. Cannabis is showing great promise in all of these areas.

As a bonus, the medical cannabis research company Ecologies Laboratories will be pushing out a merchant of death. General Atomics Aeronautical Systems, which makes the Predator drone, will have to give up its storage facility in Adelanto as the landlord has decided to lease it to Ecologies Laboratories instead.

Adelanto joins another California city, Desert Hot Springs, to become a new kind of western pioneer. It will save its economy by making millions in tax revenue and securing hundreds of jobs, and, more importantly, is embracing a future where cannabis will prove to be a medical wonder.